The Petrie-Flom Center Launches the Innovative Funding Models in Translational Research Project

The Petrie-Flom Center, January 29, 2018

January 30, 2018 - The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School is launching the

Read More

The Petrie-Flom Center Launches New Project: Precision Medicine, Artificial Intelligence, and the Law (PMAIL)

Petrie-Flom Center, January 23, 2018

The Project on Precision Medicine, Artificial Intelligence, and the Law will seek to better understand the frontiers of big data in health care diagnostics, through interdisciplinary analysis of important health law and policy issues. January 23, 2018 –…

Read More

It’s time to levy penalties for failing to report clinical trial results

STAT, January 17, 2018
Holly Fernandez Lynch (Academic Fellow Alumna and former Executive Director)

From the article: I started my first job as an attorney in the fall of 2007, days after President George W. Bush signed the Food and Drug Administration Amendments Act (FDAAA) into law. As part of my firm’s FDA group, my job was to figure out what…

Read More

Divorced couple take their fight over frozen embryos to Colorado Supreme Court

ABC News, January 10, 2018
Andrew Fies, quoting I. Glenn Cohen (Faculty Director)

From the story: What happens when the parents who created frozen embryos go to war with each other over whether to procreate with them or destroy them? That's the battle now being waged before the Colorado Supreme Court by the…

Read More

Court to weigh if one parent has the right to use frozen embryos if the other objects: Case before the Colorado Supreme Court hinges on a person's right to procreate - or not procreate.

Washington Post, January 9, 2018
Ariana Eunjung Cha, quoting I. Glenn Cohen (Faculty Director)

From the article: On Tuesday, the Colorado Supreme Court will hear oral arguments in the Rookses' case. Although several other cases have made their way to states' high courts, legal experts say the issues here are different.

Read More

PFC Spotlight: Student Fellow Alumna Emily Largent

Petrie-Flom Center, January 9, 2018

Emily Largent, JD, PhD, RN, was Peter Barton Hutt Student Fellow during the 2014-2015 academic year, while a second-year law student at Harvard Law School. Then-Academic…

Read More

A Big Pharma-funded charity that helps patients pay for drugs just sued the government

Washington Post, January 8, 2018
Carolyn Y. Johnson, quoting Christopher T. Robertson (Academic Fellow Alumnus)

From the article: These charities help patients out, but they also provide a lucrative philanthropic option for donors. Drug companies get reimbursed by government health programs or private insurers, and defuse potential criticism from sick people who can’t…

Read More

India’s Hospitals Are Filling Up With Desperate Americans

Foreign Policy, January 2, 2018
Daniel Block, quoting I. Glenn Cohen (Faculty Director)

From the article:  Medical tourism thus presents both opportunities and risks. At its best, the industry can help India grow its health care system, using the revenues generated from international patients to improve local care. At its worst, it risks shifting…

Read More

This old drug was free. Now it’s $109,500 a year.

The Washington Post, December 18, 2017
Carolyn Y. Johnson, quoting Rachel Sachs (Academic Fellow Alumna)

From the article: But the price has been on a roller coaster in recent years — zooming from a list price of $50 for a bottle of 100 pills in the early 2000s up to $13,650 in 2015, then plummeting back down to free, before skyrocketing back up to $15,001…

Read More

Trump’s zeal for deregulation could gum up the FDA, experts say

STAT, December 20, 2017
Meghana Keshavan, quoting Jonathan J. Darrow (Student Fellow Alumnus)

From the article: President Trump quite literally cut a stretch of red tape last week to emphasize his slash-and-burn stance on government deregulation. But what would sweeping regulatory change mean for public health? And could changes by his administration…

Read More

Sanofi scandal in the Philippines could spread dangerous mistrust of vaccines

STAT, December 11, 2017
Ed Silverman, quoting I. Glenn Cohen (Faculty Director)

From the article: Unfortunately, there are indications that the company, which could use a blockbuster product, should have taken its corporate foot off the gas pedal.  And to restore confidence in vaccines, a reckoning is required. …

Read More

2017’s Word Of The Year In Health Law And Bioethics: Uncertainty

Health Affairs, December 8, 2017
Carmel Shachar (Executive Director) and I. Glenn Cohen (Faculty Director)

Note: This post is the first in a series of Health Affairs posts from the Sixth Annual Health Law Year in P/Review event, held…

Read More

The Health 202: Jeff Sessions wants to put more cops on the opioid beat. Experts say that won't solve the problem.

The Washington Post, November 30, 2017
Paige Winfield Cunninghamm, quoting Rachel E. Sachs (Academic Fellow Alumna)

From the article: If the opioid epidemic was simply a problem of supply – people being able to access drugs too easily – than a targeted new effort in Appalachia announced by Attorney General Jeff Sessions yesterday would be a…

Read More

FDA-Approved Digital Pill Causes Concerns

KJZZ Radio, November 28, 2017
Steve Goldstein, interviewing I. Glenn Cohen (Faculty Director)

The first so-called digital pill has been approved by the Food and Drug Administration. It’s a version of the antipsychotic drug Abilify and contains a tiny sensor that will send a signal to a patch the user is wearing. Advocates say the digital version will keep patients from forgetting…

Read More

Digital pill offers chance of new life to old drugs

Financial Times, November 22, 2017
FT Staff, quoting I. Glenn Cohen (Faculty Director)

From the article: Amid broader concerns about how medical information may be used, Proteus says that its product complies with “all applicable laws and standards” on data protection. Patients can turn off…

Read More

Harvard Forum: Should Older Politicians And Judges Be Tested For Mental Decline?

WBUR, November 17, 2017
Carey Goldberg, describing the "Dementia and Democracy" event

This article describes the event "Dementia and Democracy: America's Aging Judges and Politicians," held on November 15, 2017 at Harvard Law School. 

Read More

A patent ploy: Allergan’s unusual legal tactic attracts political scrutiny

The Economist, November 16, 2017
Economist Staff, citing Rachel E. Sachs (Academic Fellow Alumna)

From the article: [...] The Mohawk tribe argues that it should be treated the same as a state institution. State universities have used sovereign immunity to dismiss challenges brought to the Patent Trial and Appeal Board (PTAB), which conducts patent reviews.…

Read More

First Digital Pill Approved to Worries About Biomedical ‘Big Brother’

New York Times, November 13, 2017
Pam Belluck, featuring I. Glenn Cohen (Faculty Director)

For the first time, the Food and Drug Administration has approved a digital pill — a medication embedded with a sensor that can tell doctors whether, and when, patients take their medicine. The approval, announced late on Monday, marks a significant advance in the growing field of digital…

Read More

Ohio’s Drug-Pricing Ballot Question Triggers Voter Confusion

Kaiser Health News, November 7, 2017
By Shefali Luthra, quoting Rachel E. Sachs (Academic Fellow Alumna)

From the article: Drug pricing is complex and already has caused head-scratching among policymakers and academics, noted Rachel Sachs, an associate professor…

Read More

7 ways biopharma would win — and lose — under the new tax bill

STAT News, November 2, 2017
Rebecca Robbins, citing Rachel E. Sachs (Academic Fellow Alumna)

From the article: [...] The drug industry has fiercely defended this tax credit in the past, calling it essential to encourage investment in disease areas where patients have few options — even as it has come under attack from…

Read More